Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Chronic Migraine Clinical Trials

17 recruiting trials for Chronic Migraine. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
17
Total Trials
17
Recruiting Now
2
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT04715685

Mind Body Balance for Pediatric Migraine

This study uses a factorial research design to evaluate a nurse delivered mind body intervention using different doses of 3 treatment components to determine the optimized...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 2602 locations
RECRUITINGPhase 2NCT05337033

Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial

Chronic headaches are a major cause of disability among adolescents. Cannabis products have supported the management of headaches in adults and may play a role in pediatric...

Sponsor: University of ManitobaEnrolling: 203 locations
RECRUITINGNCT06554886

A Study Investigating Peripheral Cryoneurolysis in Adults With Chronic Migraine

The trial is a research study that tests a freezing technique called cryoneurolysis to see if it helps relieve pain in adults with chronic migraine. Chronic migraine is a...

Sponsor: St. Olavs HospitalEnrolling: 121 location
RECRUITINGNCT06549270

Biochemical Profiling of Migraine Patients

Aim of the study was to assess a potential dysfunction of the endocannabidiome system (eCBome) in migraine patients. Migraine patients who will undergo preventive therapy with...

Sponsor: IRCCS National Neurological Institute "C. Mondino" FoundationEnrolling: 1001 location
RECRUITINGNCT05754190

Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA

This study relies on the use of a smartphone application (SOMA) that the investigators developed for tracking daily mood, pain, and activity status in acute pain, chronic pain,...

Sponsor: Brown UniversityEnrolling: 8001 location
RECRUITINGNCT06562400

Searching for Novel Therapeutic Approaches in Migraine Patients Resistant to Treatments

Primary working hypothesis is that NON-responders to mAbs bear a dysfunction of the endocannabidiome system (eCBome), as suggested by pre-clinical and clinical data by our group....

Sponsor: IRCCS National Neurological Institute "C. Mondino" FoundationEnrolling: 451 location
RECRUITINGNCT06409845

Effectiveness and Tolerability of Eptinezumab

The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of eptinezumab as preventive migraine treatment in a cohort of episodic or...

Sponsor: University of FlorenceEnrolling: 1002 locations
RECRUITINGPhase 3NCT06810505

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in...

Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea,...

Sponsor: AbbVieEnrolling: 42020 locations
RECRUITINGNCT04628429

CGRP Inhibition, Autonomic Function, and Migraine

The purpose of this clinical study is to better understand the function of the autonomic nervous system in patients with migraine. We aim to understand whether the autonomic...

Sponsor: Medical University of ViennaEnrolling: 1201 location
RECRUITINGPhase 3NCT07018713

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

In this clinical trial, participants with chronic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck. The purpose is to measure the change...

Sponsor: Merz Therapeutics GmbHEnrolling: 78020 locations
RECRUITINGNCT05769348

Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)

This study investigates whether unilateral and bilateral non-invasive brain stimulation, given for 20 minutes/once per day for twenty days (M-F) can reduce migraine pain. Fourty...

Sponsor: University of MichiganEnrolling: 801 location
RECRUITINGNCT06603558

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the...

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. The study will assess the...

Sponsor: AbbVieEnrolling: 30004 locations
RECRUITINGNCT06219694

Laser Acupuncture for Chronic Migraine

A single-blind randomized controlled trial was conducted from October 2024 to May 2025. Chronic migraine patients were randomly assigned in a 1:1 ratio to receive either Laser...

Sponsor: Taichung Veterans General HospitalEnrolling: 601 location
RECRUITINGNCT06322407

Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult

To assess the 6-months effects and safety of stellate ganglion block(SGB) for Chronic Migraine (CM) patients who failure to undergo preventive therapy and are seeking a more...

Sponsor: Beijing Tiantan HospitalEnrolling: 2061 location
RECRUITINGNCT03231241

Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics

Study is aimed at determining why some patients with episodic headache proceed to chronic daily or near daily headaches. The Investigators seek to discover differences in brain...

Sponsor: Stanford UniversityEnrolling: 7001 location
RECRUITINGNCT05415020

Determining the Utility of a Behavioral Intervention in Chronic Migraine

This proposal will involve a pilot study to evaluate the feasibility, acceptability, and outcomes of a lifestyle behavior protocol in managing chronic migraine. Additionally, the...

Sponsor: Mayo ClinicEnrolling: 601 location
RECRUITINGNCT03404336

Study on 30 Outpatients with Chronic Migraine Treated with Well-Being Therapy or with a Control Therapy

Chronic migraine is a disabling type of migraine and is often resistant to treatment. Non-pharmacological interventions have been investigated as potential treatment although,...

Sponsor: University of FlorenceEnrolling: 302 locations

Frequently Asked Questions

There are currently 17 clinical trials for Chronic Migraine, with 17 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Chronic Migraine, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 2 Phase 3 trials for Chronic Migraine, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.